Literature DB >> 2384281

Role of cell cholesterol in modulating antineoplastic ether lipid uptake, membrane effects and cytotoxicity.

L Diomede1, A Bizzi, A Magistrelli, E J Modest, M Salmona, A Noseda.   

Abstract

Membrane-interactive ether lipids (EL) exert toxic and antiproliferative effects on cancer cells in vitro. They appear to be selectively more toxic to cancer cells than to normal cells and thus they are ideal candidates for bone-marrow purging procedures. However, no conclusive explanation has yet been provided for this property. We now present some data indicating that the cholesterol concentration in the incubation medium modulates EL toxicity against the HL60 leukemic cell line in vitro. Furthermore, model membranes richer in cholesterol take up EL more slowly, and cell cholesterol enrichment of HL60 cells counteracts EL biophysical membrane interaction, but not toxicity, in our experimental model. However, the K562 cell line, a leukemia line less sensitive to EL toxic action, has higher levels of cell cholesterol. Our data provide evidence to explain differences in sensitivity to EL among different cell types and contribute to the understanding of the mechanism of action of EL.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2384281     DOI: 10.1002/ijc.2910460234

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  10 in total

1.  Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro.

Authors:  Cécile Ménez; Marion Buyse; Madeleine Besnard; Robert Farinotti; Philippe M Loiseau; Gillian Barratt
Journal:  Antimicrob Agents Chemother       Date:  2006-09-11       Impact factor: 5.191

2.  The effect of culture medium composition on ether lipid cytotoxic activity.

Authors:  L Diomede; B Piovani; E J Modest; M Salmona
Journal:  Lipids       Date:  1993-03       Impact factor: 1.880

3.  Structure-function relationships of alkyl-lysophospholipid analogs in selective antitumor activity.

Authors:  W R Vogler; A C Olson; J Hajdu; M Shoji; R Raynor; J F Kuo
Journal:  Lipids       Date:  1993-06       Impact factor: 1.880

4.  Effect of cell density on cytotoxicity of ether lipid analogues in variants of B16 murine melanoma.

Authors:  L L Trulla; A Magistrelli; M Salmona; M T Tacconi
Journal:  Lipids       Date:  1993-05       Impact factor: 1.880

5.  Relationship of cell survival, drug dose, and drug uptake after 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine treatment.

Authors:  K Fujiwara; L W Daniel; E J Modest; C A Wallen
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Inward translocation of the phospholipid analogue miltefosine across Caco-2 cell membranes exhibits characteristics of a carrier-mediated process.

Authors:  Cécile Ménez; Marion Buyse; Robert Farinotti; Gillian Barratt
Journal:  Lipids       Date:  2007-02-06       Impact factor: 1.880

7.  Influence of platelet-activating factor, lyso-platelet-activating factor and edelfosine on Langmuir monolayers imitating plasma membranes of cell lines differing in susceptibility to anti-cancer treatment: the effect of plasmalogen level.

Authors:  Michał Flasiński; Katarzyna Hąc-Wydro; Paweł Wydro; Patrycja Dynarowicz-Łątka
Journal:  J R Soc Interface       Date:  2014-04-02       Impact factor: 4.118

Review 8.  Membrane-interactive lipids as experimental anticancer drugs.

Authors:  W E Berdel
Journal:  Br J Cancer       Date:  1991-08       Impact factor: 7.640

9.  Interactions of alkylphosphocholines with model membranes-the Langmuir monolayer study.

Authors:  Anita Wnętrzak; Kazimierz Lątka; Patrycja Dynarowicz-Łątka
Journal:  J Membr Biol       Date:  2013-05-15       Impact factor: 1.843

10.  Growth arrest vs direct cytotoxicity and the importance of molecular structure for the in vitro anti-tumour activity of ether lipids.

Authors:  M Lohmeyer; P Workman
Journal:  Br J Cancer       Date:  1995-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.